Rengan Rajaratnam Pleads Not Guilty

March 25 (Bloomberg) -- Gigi Stone reports on today's top headlines. She speaks on Bloomberg Television's "Bottom Line." (Source: Bloomberg)

Teva Said Close to Closing $40.5 Billion Allergan Deal
20:05 - The U.S. Federal Trade Commission is close to signing off on Teva Pharmaceutical's deal to buy Allergan Plc's generics unit for $40.5 billion according to people familiar with the matter. Bloomberg's Elliot Gotkine reports on "Bloomberg Markets Middle East." (Source: Bloomberg)
  • Bracing for Yet Another Global Banking Crisis
  • Brexit Brews Trouble for SABMiller-AB InBev Deal
  • Ford CEO: Brexit and Lower Pound Hurt Us